Your browser doesn't support javascript.
loading
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Goddard, Jack; Castle, Jemma; Southworth, Emily; Fletcher, Anya; Crosier, Stephen; Martin-Guerrero, Idoia; García-Ariza, Miguel; Navajas, Aurora; Masliah-Planchon, Julien; Bourdeaut, Franck; Dufour, Christelle; Ayrault, Olivier; Goschzik, Tobias; Pietsch, Torsten; Sill, Martin; Pfister, Stefan M; Rutkowski, Stefan; Richardson, Stacey; Hill, Rebecca M; Williamson, Daniel; Bailey, Simon; Schwalbe, Edward C; Clifford, Steven C; Hicks, Debbie.
Afiliação
  • Goddard J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Castle J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Southworth E; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Fletcher A; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Crosier S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Martin-Guerrero I; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • García-Ariza M; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain.
  • Navajas A; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Masliah-Planchon J; Department of Pediatric Hematology and Oncology, Cruces University Hospital, Barakaldo, Spain.
  • Bourdeaut F; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Dufour C; Unité de Génétique Somatique, Institut Curie, Paris, France.
  • Ayrault O; SIREDO Pediatric Oncology Center, Curie Institute, Paris, France.
  • Goschzik T; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Rue Edouard Vaillant, 94805, Villejuif, France.
  • Pietsch T; UMR 3347, INSERM U1021, Institut Curie, PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS, Paris, France.
  • Sill M; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
  • Pfister SM; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
  • Rutkowski S; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Richardson S; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Hill RM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Williamson D; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Bailey S; Department of Paediatric Haematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schwalbe EC; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
  • Hicks D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
Acta Neuropathol ; 145(5): 651-666, 2023 05.
Article em En | MEDLINE | ID: mdl-37014508
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article